BRENT NECAISE: Open Payments
NPI 1194222885 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 36 payments from 12 companies in 2025. Trend: 2023 $481 · 2024 $613 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 1 | $154 |
| Axsome Therapeutics, Inc. | 6 | $133 |
| Alkermes, Inc. | 4 | $91 |
| ABBVIE INC. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
Products named: VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, Auvelity, VRAYLAR, TRINTELLIX, ARISTADA, REXULTI, HETLIOZ, Qelbree.
Industry payments across TN — which companies pay providers there.
